What Happens If You Get Pregnant on Wegovy

The misconception worth correcting first

A number of people assume that because Wegovy reduces appetite and affects metabolic hormones, any pregnancy that occurs on treatment is automatically at risk. That is not quite what the evidence says, and framing it that way causes unnecessary panic. What the guidance actually reflects is that animal studies showed foetal harm at exposures comparable to therapeutic human doses, and that there is simply not enough human trial data to establish safety in pregnancy. The precautionary position (stop the medicine and seek medical advice) is based on absence of evidence as much as evidence of harm. That distinction matters for how you approach the conversation with your GP. You can read more about what happens if you fall pregnant on Wegovy, including how the guidance applies at different stages, to help frame that discussion.

The Wegovy SmPC and the NHS medicines page for semaglutide both state that Wegovy should not be used during pregnancy. This is not a vague caution; it is a specific contraindication across all trimesters. If you are reading this because you have just found out you are pregnant, the practical instruction is the same regardless of how far along you are: stop the injections, and call your GP or midwifery team today.

What happens to the body when Wegovy is stopped in pregnancy

Stopping Wegovy abruptly is the right call in this situation, even though it can feel counterintuitive if you have been told to maintain consistent dosing for best results. Semaglutide has a long half-life (roughly one week) so it clears from the body gradually over several weeks after the last injection. The NHS England guidance on weight-management injections advises that women who are planning to become pregnant should stop treatment at least two months before trying to conceive, precisely because of this slow clearance. If conception has already happened, stopping now still matters.

Some women notice a return of appetite and a change in how quickly they feel full after stopping, and understanding what happens when you take Wegovy can help clarify why these shifts occur as the medicine's GLP-1 effect unwinds. Pregnancy itself also changes appetite, nausea patterns and weight in significant ways, so any changes you notice are worth mentioning to your midwife rather than attributing to one cause. You can read more about what stopping Wegovy feels like in more detail, though the pregnancy context adds layers that your obstetric team are best placed to address.

Contraception, fertility and planning ahead

One fact that surprises many patients is that weight loss itself can restore or increase fertility, particularly in women with polycystic ovary syndrome or irregular cycles. Some people start Wegovy expecting weight management, and find their cycle regularises in ways they had not anticipated. This is not a side effect of the medicine per se (it is a consequence of reduced body weight) but it means contraception planning matters from the first pen, not just once a therapeutic dose is reached.

For women on oral contraceptives, there is a specific point about Wegovy worth knowing. Unlike tirzepatide, there is no established evidence of semaglutide reducing oral contraceptive absorption to a clinically meaningful degree, according to NHS guidance. That said, the overall advice remains: use reliable contraception throughout treatment and for two months after the last dose if pregnancy is not the plan. If you are thinking about trying to conceive after treatment, there is a fuller picture of life after Wegovy that covers the planning timeline. And if you have questions about stopping early or adjusting treatment, what happens if you stop Wegovy before completing the course is addressed separately.

Who to speak to, and when to go urgently

Your GP or midwife is the right first contact. They can record the exposure in your antenatal notes, arrange appropriate monitoring, and refer you if needed. If you are currently a patient with a private service such as ours at nume, your prescriber should also be notified so your treatment records are updated and no further doses are dispatched. Our clinical team, which you can read about via our lead prescriber's profile, can support that transition, but obstetric care sits firmly with your GP and midwifery team.

If you experience any unusual symptoms after stopping (severe nausea beyond normal morning sickness, acute abdominal pain, or signs of an allergic reaction) seek medical attention promptly. Side effects can be reported via the MHRA Yellow Card scheme, which also accepts reports related to pregnancy exposure. For anyone thinking about starting Wegovy who has not yet done so, a clinical consultation is the starting point, our prescribers review every case individually, and contraceptive status forms part of that assessment. Start your free consultation if you would like that conversation before beginning treatment.

For context on how Wegovy works and the broader picture of this treatment, the Wegovy overview page covers the mechanism, clinical evidence and what to expect. If you have been considering injectable weight-loss treatments more generally, the weight-loss treatment options page sets out what is available in the UK.